BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9649156)

  • 1. Aberrant crypt foci in patients with colorectal cancer.
    Roncucci L; Modica S; Pedroni M; Tamassia MG; Ghidoni M; Losi L; Fante R; Di Gregorio C; Manenti A; Gafa L; Ponz de Leon M
    Br J Cancer; 1998 Jun; 77(12):2343-8. PubMed ID: 9649156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of aberrant crypt foci and microadenomas in human colon.
    Roncucci L; Medline A; Bruce WR
    Cancer Epidemiol Biomarkers Prev; 1991; 1(1):57-60. PubMed ID: 1845171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant crypt foci in the human colon: frequency and histologic patterns in patients with colorectal cancer or diverticular disease.
    Nascimbeni R; Villanacci V; Mariani PP; Di Betta E; Ghirardi M; Donato F; Salerni B
    Am J Surg Pathol; 1999 Oct; 23(10):1256-63. PubMed ID: 10524527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and quantification of aberrant crypt foci and microadenomas in the human colon.
    Roncucci L; Stamp D; Medline A; Cullen JB; Bruce WR
    Hum Pathol; 1991 Mar; 22(3):287-94. PubMed ID: 1706308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histomorphology of aberrant crypt foci in colorectal carcinoma.
    Norlida AO; Phang KS
    Malays J Pathol; 2010 Dec; 32(2):111-6. PubMed ID: 21329182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histology of aberrant crypt foci in the human colon.
    Di Gregorio C; Losi L; Fante R; Modica S; Ghidoni M; Pedroni M; Tamassia MG; Gafà L; Ponz de Leon M; Roncucci L
    Histopathology; 1997 Apr; 30(4):328-34. PubMed ID: 9147080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azoxymethane-induced aberrant crypt foci and colorectal tumors in F344 rats: sequential analysis of growth.
    Ghirardi M; Nascimbeni R; Villanacci V; Fontana MG; Di Betta E; Salerni B
    Eur Surg Res; 1999; 31(3):272-80. PubMed ID: 10352356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant crypt foci in patients with neoplastic and nonneoplastic colonic disease.
    Bouzourene H; Chaubert P; Seelentag W; Bosman FT; Saraga E
    Hum Pathol; 1999 Jan; 30(1):66-71. PubMed ID: 9923929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant crypt foci in human colons: distribution and histomorphologic characteristics.
    Shpitz B; Bomstein Y; Mekori Y; Cohen R; Kaufman Z; Neufeld D; Galkin M; Bernheim J
    Hum Pathol; 1998 May; 29(5):469-75. PubMed ID: 9596270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of adenomatous aberrant crypt foci (ACF) from hyperplastic ACF with concomitant increase in cell proliferation.
    Otori K; Sugiyama K; Hasebe T; Fukushima S; Esumi H
    Cancer Res; 1995 Nov; 55(21):4743-6. PubMed ID: 7585496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics.
    Roncucci L; Pedroni M; Vaccina F; Benatti P; Marzona L; De Pol A
    Cell Prolif; 2000 Feb; 33(1):1-18. PubMed ID: 10741640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scanning electron microscopy of aberrant crypt foci in human colorectal mucosa.
    Vaccina F; Scorcioni F; Pedroni M; Tamassia MG; De Leon MP; De Pol A; Marzona L; Roncucci L
    Anticancer Res; 1998; 18(5A):3451-6. PubMed ID: 9858923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell kinetic evaluation of human colonic aberrant crypts. (Colorectal Cancer Study Group of the University of Modena and the Health Care District 16, Modena, Italy).
    Roncucci L; Pedroni M; Fante R; Di Gregorio C; Ponz de Leon M
    Cancer Res; 1993 Aug; 53(16):3726-9. PubMed ID: 8339283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abberant crypt foci -- importance in colorectal carcinogenesis and expression of p53 and mdm2: a changing concept.
    Das P; Jain D; Vaiphei K; Wig JD
    Dig Dis Sci; 2008 Aug; 53(8):2183-8. PubMed ID: 18080767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive effect of aspirin on aberrant crypt foci in patients with colorectal cancer.
    Shpitz B; Klein E; Buklan G; Neufeld D; Nissan A; Freund HR; Grankin M; Bernheim J
    Gut; 2003 Nov; 52(11):1598-601. PubMed ID: 14570729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of preneoplastic lesions as mucin-depleted foci in patients with sporadic colorectal cancer.
    Sakai E; Morioka T; Yamada E; Ohkubo H; Higurashi T; Hosono K; Endo H; Takahashi H; Takamatsu R; Cui C; Shiozawa M; Akaike M; Samura H; Nishimaki T; Nakajima A; Yoshimi N
    Cancer Sci; 2012 Jan; 103(1):144-9. PubMed ID: 22017323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant crypt focus size predicts distal polyp histopathology.
    Kim J; Ng J; Arozulllah A; Ewing R; Llor X; Carroll RE; Benya RV
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1155-62. PubMed ID: 18483337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
    Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
    Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K-ras and p53 mutations in human colorectal aberrant crypt foci.
    Losi L; Roncucci L; di Gregorio C; de Leon MP; Benhattar J
    J Pathol; 1996 Mar; 178(3):259-63. PubMed ID: 8778329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
    Hurlstone DP; Karajeh M; Sanders DS; Drew SK; Cross SS
    Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.